Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 5Completed 3Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Hepatitis B, Chronic 2Carcinoma, Hepatocellular 2Neoplasms 1Fibrosis 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Tenofovir × Clear all
NCT02650271 2024-01-23

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Guangxi Medical University

Phase 3 Completed
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02081469 2020-02-05

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Chang Gung Memorial Hospital

Phase 4 Completed
100 enrolled

Neoplasms, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡